H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 6.1% of adults in Seattle have diagnosed diabetes — 5.9 points below the U.S. 12% figure. Census population 749,256. Washington Medicare wound biologics: Noridian Healthcare Solutions (JF). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Seattle clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Seattle storefront.
Biologic Solutions for Chronic Wounds in Seattle, WA for clinics & physicians. Biologic solutions for chro… Compliance support & pricing — contact Hawk Medical.
Joe Bradley will tell you the same thing he tells his own staff: epidemiology first, then MAC, then SKU. CDC PLACES (2023, crude) estimates 6.1% of adults in Seattle have diagnosed diabetes — 5.9 points below the U.S. 12% figure. 6.1% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. Then we pick biologic solutions chronic wounds against that mix.
National Biologic Solutions for Chronic Wounds notes (how the product actually works)JF reviewers still want serial wound measurements and conservative-care history before CTPs, whether diabetes in Seattle is 6.1% or not. PLACES is planning data. The LCD is the claim.
Vendor consolidation is boring on purpose: one account, IFUs filed, JF articles mapped. 6.1% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. Pricing scripts have to match that mix. We will help write them. We will not book your patients.
CDC PLACES (2023, crude prevalence) estimates 6.1% of adults — 5.9 points below the U.S. 12% figure. Obesity is 22.2%; arthritis is 17%. That is place-level BRFSS modeling, not a clinic census and not a Seattle trial.
No. Hematogel is a PRP-based wound gel pathway with its own application and documentation. Skin substitutes/CTPs follow Noridian Healthcare Solutions CTP articles. Mixing those codes is a billing error.
The 96.5% figure is a product-level clinical experience statistic published on our wound-care materials — not a city-specific trial. Your outcomes will depend on patient selection, offloading, and follow-up.
CDC estimates 12% of the U.S. population has diabetes (40.1 million people, 2023). America's Health Rankings (BRFSS 2024) shows state adult rates from Colorado 8.4% to West Virginia 18.4%. We do not publish a made-up city diabetes count. Use national/state published rates plus your panel.
If you operate in Washington and another MAC state, say it on the first call. JF will not port 1:1. We would rather split utilization than watch a sister clinic copy Seattle tickets into the wrong jurisdiction.
Contact us to learn how Hawk Medical supports practices in Seattle, WA.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Seattle is JF geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Seattle — 5.9 points below the U.S. 12% figure. Planning input, not an outcomes claim.
Washington Part B wound biologics follow this contractor (siblings: AK, AZ, ID, MT, ND, OR, SD, UT, WY). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Seattle. Useful for joint-program math; still needs a diagnosis and privileging.
No Seattle storefront. Joe Bradley is an active practice owner. biologic solutions chronic wounds stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.